Substantia nigra pars compacta dopaminergic neuron (SNc dopaminergic neuron (A9))

A9-type midbrain dopaminergic neurons are large, angular dopamine-producing cells in the substantia nigra pars compacta. They predominantly project to the dorsolateral striatum (putamen and caudate in humans), facilitating voluntary motor control. These neurons are uniquely vulnerable to degeneration in Parkinson’s disease—their loss leads to the hallmark motor dysfunction of the disorder. Key distinguishing features include the expression of GIRK2 potassium channels and the transcription factor PITX3, and their development and innervation patterns are well studied both for understanding disease mechanisms and for cell-based therapies. If more molecular specificity is needed, markers such as tyrosine hydroxylase, FOXA2, LMX1A, and GIRK2 can help identify these neurons in research and potential clinical applications.

Other names

Substantia nigra dopaminergic neuronSNc DA neuronA9 DA neuronA9-type neuron

Dopamine replacement (levodopa metabolizes to dopamine); Dopaminergic receptor agonism; Inhibition of dopamine breakdown; Cell replacement or restoration of dopaminergic innervation.